| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642541A Method for treating cognitive disorders |
| 07/20/2005 | CN1642540A Suramin and derivatives thereof as topical microbicide and contraceptive |
| 07/20/2005 | CN1642539A Diclofenac sodium oral pharmaceutical |
| 07/20/2005 | CN1642538A Use of adapalene for the treatment of dermatological disorders |
| 07/20/2005 | CN1642537A Ibuprofen solution for hard shell capsules |
| 07/20/2005 | CN1642536A Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
| 07/20/2005 | CN1642535A Tuberculosis treatment using pleuromutilin derivatives |
| 07/20/2005 | CN1642534A HFA suspension formulations containing an anticholinergic |
| 07/20/2005 | CN1642532A Sustained release formulation of tramadol |
| 07/20/2005 | CN1642531A Palatable chewable tablet |
| 07/20/2005 | CN1642530A Compressed tablets comprising microcapsules with modified release |
| 07/20/2005 | CN1642529A Matrix for sustained, invariant and independent release of active compounds |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1642527A Stabilized natural cannabinoid formulation |
| 07/20/2005 | CN1642526A Formulations of atorvastatin stabilized with alkali metal additions |
| 07/20/2005 | CN1642525A HFA suspension formulations of an anhydrate |
| 07/20/2005 | CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 07/20/2005 | CN1642415A Palatable oral suspension and method |
| 07/20/2005 | CN1640885A Loguat leaf total dehydrocamphenilic acid and its preparation method and use |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1640873A Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof |
| 07/20/2005 | CN1640870A Ibuprofen ester, medically-acceptable salt, and its preparing process and medicinal composition |
| 07/20/2005 | CN1640429A Method for extracting effective component from sophora alopecuroide for reducing blood fat and its medicinal use |
| 07/20/2005 | CN1640410A Helicid capsule agent |
| 07/20/2005 | CN1640409A High-purity scutellarin injection agent |
| 07/20/2005 | CN1640408A Multifunctional anti virus lozenge |
| 07/20/2005 | CN1640407A Anti-thrombus small-dose aspirin injection agent and its preparing method |
| 07/20/2005 | CN1640406A Drug-dropping and intelligence-promoting medicine using ocotillol as effective component, and its preparing method and use |
| 07/20/2005 | CN1640405A Method for producing d-alpha-succinic tocopherol granule |
| 07/20/2005 | CN1640404A Ganciclovir injection liquid and its production method |
| 07/20/2005 | CN1640403A Use of cis-butenedionic acylhydrazine for preparing medicine for treating cancers |
| 07/20/2005 | CN1640402A Stable naloxone powder for injection |
| 07/20/2005 | CN1640401A Tetrandrine preparation foreyes |
| 07/20/2005 | CN1640400A Felodipine controlled-release preparation |
| 07/20/2005 | CN1640399A Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease |
| 07/20/2005 | CN1640398A Paracetamol hydrochloride and dextromethorphan hydrochloride orally disintegrating tablet and its preparing method |
| 07/20/2005 | CN1640397A Kurarinol drop pill and its preparing method |
| 07/20/2005 | CN1640396A Novel medicinal compositions |
| 07/20/2005 | CN1640395A Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 07/20/2005 | CN1640394A Andrographolide sulfonic acid sodium lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640393A Use of tea polyphenol for preparing medicine for preventing and treating lipsotrichia induced from chemotherapy |
| 07/20/2005 | CN1640392A High-dose hydroxy safflower yellow A or its medically-acceptable salt application for preparing medicine for cerebral apoplexy induced from being ischemic |
| 07/20/2005 | CN1640391A Tanshinon IIA sulfonic acid sodium glucose injection liquid and its preparing method |
| 07/20/2005 | CN1640390A Novel sodium houttuynin lyophilized powder for injection and its preparing method |
| 07/20/2005 | CN1640389A Medicine for treating bacterial vaginitis and its preparing method |
| 07/20/2005 | CN1640388A Tulobuterol containing pressure-sensitive adhesive, transdermal paster, and its preparing method and use |
| 07/20/2005 | CN1640386A Oral solid medicine release system |
| 07/20/2005 | CN1640385A Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 07/20/2005 | CN1211396C Female hormore compound of bone tendency, preparing method and application thereof |
| 07/20/2005 | CN1211395C Female hormore compound of bone tendency, preparing method and application thereof |
| 07/20/2005 | CN1211391C Crystal form of pifuadefuwei |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211385C Bicyclic imidazo-5-yl-amine derivs. |
| 07/20/2005 | CN1211384C Thiadiazolyl and oxidiazolyl phenyl oxazolidinone antibacterial agent |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211381C Substituted imidazoles useful in treatment of inflammatory diseases |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211370C Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/20/2005 | CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them |
| 07/20/2005 | CN1211359C New phenalkyoxy-phenyl derivatives |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/20/2005 | CN1211351C Alpha-amino acid amides, prepn. thereof and the therapeutic use thereof |
| 07/20/2005 | CN1211335C Compounds for the suppression of HIV TAT transactivation |
| 07/20/2005 | CN1211164C Medium milling |
| 07/20/2005 | CN1211125C Olopatadine formulations for topical administration |
| 07/20/2005 | CN1211124C Thixotropic formulations for filling hard capsules |
| 07/20/2005 | CN1211117C Preparation of Xinxue granules |
| 07/20/2005 | CN1211106C Cough-relieving spray |
| 07/20/2005 | CN1211098C Use of centella general glucoside for resisting depression |
| 07/20/2005 | CN1211091C Polyallylamine polymers for treating hypercholesterolemia |
| 07/20/2005 | CN1211090C Preparation of polyacrylicate sodium hemostatic for treating arterovenous hemorrhage |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211088C Application of emodin analog EMD-31 for treating tumor |
| 07/20/2005 | CN1211087C Competitive progesterone antagnoists for regulating female fertility as required |
| 07/20/2005 | CN1211086C Sustained release ranolazine formulations |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211084C Technology for producing Dekualinum lozenge |
| 07/20/2005 | CN1211083C Sophoridine and its application in analgesic |
| 07/20/2005 | CN1211082C Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 07/20/2005 | CN1211081C Use of Tamsulosin preparing preparations for treating neurogenic bladder associated dysuria |
| 07/20/2005 | CN1211080C Method for preparing microcapsule |
| 07/20/2005 | CN1211079C Stable slow-releasing oral administration composition |
| 07/20/2005 | CN1211077C Histamine H2 antagonist effervescent composition |
| 07/20/2005 | CN1211074C Solid-state liposome contaniing calcareous and its preparation method |
| 07/20/2005 | CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 07/20/2005 | CN1211058C Container for oxazolidone intravenous solution and method for preventing loss of oxazolidone |
| 07/19/2005 | USRE38761 Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
| 07/19/2005 | US6919483 Tumor necrosis factor (TNF alpha) inhibitors for treatinginflammatory/infectious/autoimmune/proliferative diseases; anticancer/tumor/diabetic/arthritic agents |
| 07/19/2005 | US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury |
| 07/19/2005 | US6919470 Aryl and heteroaryl sulfonates |
| 07/19/2005 | US6919462 Using 1-aryl-3-cyano-5-aminopyrazole compound |
| 07/19/2005 | US6919461 Anticancer agents; antiarthritic agents |
| 07/19/2005 | US6919460 Making 2-bromo-1-pyridin-3-yl-ethanol by reducing the ketone, protecting the alcohol, condensing with a p-(heterocycle)-phenoxyethylamine, then deprotecting to form 2-(2-(4-heterocycyl-phenoxy)-ethylamino)-1-pyridin-3-ylethanol |